604(top 100%)
papers
126.4K(top 0.1%)
citations
125(top 100%)
h-index
353(top 100%)
g-index
692
all documents
145.8K
doc citations
9.7K
citing journals
100
times ranked

Publications

640 papers • 145,772 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Delirium is more common and associated with worse outcomes in Parkinson’s disease compared to older adult controls: results of two prospective longitudinal cohort studies
Age and Ageing, 2024, 53,
1.810Citations (PDF)
2Temporal trends in population attributable fractions of modifiable risk factors for dementia: a time-series study of the English Longitudinal Study of Ageing (2004–2019)
BMC Medicine, 2024, 22,
7.56Citations (PDF)
3Receipt of help by people with cognitive impairment: results from the English Longitudinal Study of Ageing
Aging and Mental Health, 2023, 27, 272-280
2.72Citations (PDF)
4Predictors of loneliness during the Covid-19 pandemic in people with dementia and their carers in England: findings from the DETERMIND-C19 study
Aging and Mental Health, 2023, 27, 521-532
2.712Citations (PDF)
5Extremes of baseline cognitive function determine the severity of delirium: a population study
Brain, 2023, 146, 2132-2141
8.916Citations (PDF)
6Delirium and Delirium Severity Predict the Trajectory of the Hierarchical Assessment of Balance and Mobility in Hospitalized Older People: Findings From the DECIDE Study3.613Citations (PDF)
7Visual Impairment and Risk of Dementia in 2 Population-Based Prospective Cohorts: UK Biobank and EPIC-Norfolk3.617Citations (PDF)
8Evaluation of Bedside Tests of Attention and Arousal Assessing Delirium in Parkinson’s Disease, Dementia, and Older Adults3.74Citations (PDF)
9Association of major blood lipids with post‐stroke dementia: A community‐based cohort study3.76Citations (PDF)
10The need for a better global dementia response
Lancet Neurology, The, 2022, 21, 115-116
12.911Citations (PDF)
11Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Lancet Public Health, The, 2022, 7, e105-e125
12.53,421Citations (PDF)
12Epidemiologic Trends, Social Determinants, and Brain Health: The Role of Life Course Inequalities
Stroke, 2022, 53, 437-443
5.137Citations (PDF)
13The challenges of open access data
Lancet, The, 2022, 399, 517
14.85Citations (PDF)
14Association of Systolic Blood Pressure With Dementia Risk and the Role of Age, U-Shaped Associations, and Mortality
JAMA Internal Medicine, 2022, 182, 142
6.184Citations (PDF)
15Ethics, evidence, and the environment in dementia risk reduction – Authors' reply
The Lancet Healthy Longevity, 2022, 3, e132-e133
6.31Citations (PDF)
16A comparison over 2 decades of disability-free life expectancy at age 65 years for those with long-term conditions in England: Analysis of the 2 longitudinal Cognitive Function and Ageing Studies
PLoS Medicine, 2022, 19, e1003936
8.29Citations (PDF)
17Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis5.416Citations (PDF)
18The effect of baseline cognition and delirium on long-term cognitive impairment and mortality: a prospective population-based study
The Lancet Healthy Longevity, 2022, 3, e232-e241
6.358Citations (PDF)
19Factors Predicting Engagement of Older Adults With a Coach-Supported eHealth Intervention Promoting Lifestyle Change and Associations Between Engagement and Changes in Cardiovascular and Dementia Risk: Secondary Analysis of an 18-Month Multinational Randomized Controlled Trial5.239Citations (PDF)
20Evaluation of routinely collected records for dementia outcomes in UK: a prospective cohort study
BMJ Open, 2022, 12, e060931
2.08Citations (PDF)
21Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
Acta Neuropathologica, 2022, 144, 27-44
7.8126Citations (PDF)
22Population-Based Studies in Dementia and Ageing Research: A Local and National Experience in Cambridgeshire and the UK2.27Citations (PDF)
23The limitations of large-scale volunteer databases to address inequalities and global challenges in health and aging
Nature Aging, 2022, 2, 775-783
15.681Citations (PDF)
24A Scoping Review of the Conceptual Differentiation of Technology for Healthy Aging
Gerontologist, The, 2021, 61, e345-e369
3.013Citations (PDF)
25Autism screening and conditional cash transfers in Chile: Using the Quantitative Checklist (Q-CHAT) for early autism detection in a low resource setting
Autism, 2021, 25, 932-945
6.023Citations (PDF)
26Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer’s and small vessel disease pathologies
Brain Pathology, 2021, 31,
4.813Citations (PDF)
27Recurrent delirium over 12 months predicts dementia: results of the Delirium and Cognitive Impact in Dementia (DECIDE) study
Age and Ageing, 2021, 50, 914-920
1.893Citations (PDF)
28Measuring Quality of Life in Carers of People With Dementia: Development and Psychometric Evaluation of Scales measuring the Impact of DEmentia on CARers (SIDECAR)
Gerontologist, The, 2021, 61, e1-e11
3.017Citations (PDF)
29Amyloid in the ageing brain: New frameworks and perspectives
Aging Brain, 2021, 1, 100008
2.22Citations (PDF)
30Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 20194.9117Citations (PDF)
31Healthy ageing for all? Comparisons of socioeconomic inequalities in health expectancies over two decades in the Cognitive Function and Ageing Studies I and II5.232Citations (PDF)
32Frailty and neuropathology in relation to dementia status: the Cambridge City over-75s Cohort study
International Psychogeriatrics, 2021, 33, 1035-1043
1.025Citations (PDF)
33Inclusive education in the European Union: A fuzzy-set qualitative comparative analysis of education policy for autism
Social Work in Public Health, 2021, 36, 286-299
1.723Citations (PDF)
34Health financing for universal health coverage in Sub-Saharan Africa: a systematic review3.6118Citations (PDF)
35The Relationship Between Cognitive Performance Using Tests Assessing a Range of Cognitive Domains and Future Dementia Diagnosis in a British Cohort: A Ten-Year Prospective Study2.79Citations (PDF)
36The changing health needs of the UK population
Lancet, The, 2021, 397, 1979-1991
14.860Citations (PDF)
37Education and austerity in the European Union from an autism perspective: Policy mapping in Ireland, Portugal, Italy, and Greece
European Policy Analysis, 2021, 7, 508-520
2.72Citations (PDF)
38Quantitative Checklist for Autism in Toddlers (Q-CHAT). A population screening study with follow-up: the case for multiple time-point screening for autism
BMJ Paediatrics Open, 2021, 5, e000700
1.738Citations (PDF)
39LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19
Lancet, The, 2021, 397, 1915-1978
14.877Citations (PDF)
40Hospitalisation without delirium is not associated with cognitive decline in a population-based sample of older people—results from a nested, longitudinal cohort study
Age and Ageing, 2021, 50, 1675-1681
1.814Citations (PDF)
41Association of Race/Ethnicity and Social Disadvantage With Autism Prevalence in 7 Million School Children in England
JAMA Pediatrics, 2021, 175, e210054
6.9199Citations (PDF)
42Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial
BMJ Open, 2021, 11, e049762
2.034Citations (PDF)
43Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study
The Lancet Healthy Longevity, 2021, 2, e426-e435
6.365Citations (PDF)
44Montreal Cognitive Assessment for the detection of dementia
The Cochrane Library, 2021, 2021,
2.558Citations (PDF)
45Do school closures and school reopenings affect community transmission of COVID-19? A systematic review of observational studies
BMJ Open, 2021, 11, e053371
2.0114Citations (PDF)
46The legacy of the 2013 G8 Dementia Summit: successes, challenges, and potential ways forward
The Lancet Healthy Longevity, 2021, 2, e455-e457
6.38Citations (PDF)
47Association of Thyroid Dysfunction With Cognitive Function
JAMA Internal Medicine, 2021, 181, 1440
6.196Citations (PDF)
48Perceived causes of mental illness and views on appropriate care pathways among Indonesians3.211Citations (PDF)
49Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia9.249Citations (PDF)
50Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain5.137Citations (PDF)
51Cohort Profile Update: The Harmonised Cognitive Assessment Protocol Sub-study of the English Longitudinal Study of Ageing (ELSA-HCAP)5.242Citations (PDF)
52Public health research in the UK to understand and mitigate the impact of COVID-19 and COVID-19 response measures3.49Citations (PDF)
53Societal and equity challenges for Brain Health Services. A user manual for Brain Health Services—part 6 of 66.824Citations (PDF)
54Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 66.887Citations (PDF)
55Dementia in the older population is associated with neocortex content of serum amyloid P component3.811Citations (PDF)
56Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 66.844Citations (PDF)
57Inequalities in mental health: predictive processing and social life4.92Citations (PDF)
58Is there a dose–response relationship between musical instrument playing and later-life cognition? A cohort study using EPIC-Norfolk data
Age and Ageing, 2021, 50, 220-226
1.83Citations (PDF)
59Design and Development of a Mobile Health (mHealth) Platform for Dementia Prevention in the Prevention of Dementia by Mobile Phone Applications (PRODEMOS) Project2.524Citations (PDF)
60Physical Activity Predicts Population-Level Age-Related Differences in Frontal White Matter3.631Citations (PDF)
61Mortality risk of loneliness in the oldest old over a 10-year follow-up
Aging and Mental Health, 2020, 24, 35-40
2.721Citations (PDF)
62Changing prevalence and treatment of depression among older people over two decades2.338Citations (PDF)
63Cognitive Diversity in a Healthy Aging Cohort: Cross-Domain Cognition in the Cam-CAN Project
Journal of Aging and Health, 2020, 32, 1029-1041
2.023Citations (PDF)
64Longitudinal analysis of the impact of loneliness on cognitive function over a 20-year follow-up
Aging and Mental Health, 2020, 24, 1815-1821
2.730Citations (PDF)
65Putative risk alleles for LATE‐NC with hippocampal sclerosis in population‐representative autopsy cohorts
Brain Pathology, 2020, 30, 364-372
4.827Citations (PDF)
66Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: A systematic review and meta-analysis
Ageing Research Reviews, 2020, 57, 100962
12.168Citations (PDF)
67DETERMinants of quality of life, care and costs, and consequences of INequalities in people with Dementia and their carers (DETERMIND): A protocol paper2.423Citations (PDF)
68Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Lancet, The, 2020, 396, 1204-1222
14.814,522Citations (PDF)
69The Impact of Including Costs and Outcomes of Dementia in a Health Economic Model to Evaluate Lifestyle Interventions to Prevent Diabetes and Cardiovascular Disease
Medical Decision Making, 2020, 40, 912-923
2.411Citations (PDF)
70Autism and education—international policy in small EU states: policy mapping in Malta, Cyprus, Luxembourg and Slovenia0.314Citations (PDF)
71Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review
Journal of Alzheimer's Disease, 2020, 76, 1609-1626
2.749Citations (PDF)
72Education and the moderating roles of age, sex, ethnicity and apolipoprotein epsilon 4 on the risk of cognitive impairment3.713Citations (PDF)
73Quotas, and Anti‐discrimination Policies Relating to Autism in the <scp>EU</scp>: Scoping Review and Policy Mapping in Germany, France, Netherlands, United Kingdom, Slovakia, Poland, and Romania
Autism Research, 2020, 13, 1397-1417
5.116Citations (PDF)
74Autism and education—Teacher policy in Europe: Policy mapping of Austria, Hungary, Slovakia and Czech Republic2.413Citations (PDF)
75Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain Cohort1.910Citations (PDF)
76Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II
BMC Geriatrics, 2020, 20,
3.363Citations (PDF)
77Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Lancet, The, 2020, 396, 413-446
14.88,266Citations (PDF)
78Health inequalities in stroke and dementia prevention
Lancet Neurology, The, 2020, 19, 567
12.92Citations (PDF)
79Transcriptomic Analysis of Age-Associated Periventricular Lesions Reveals Dysregulation of the Immune Response4.59Citations (PDF)
80Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus2.733Citations (PDF)
81Association of Prior Atherosclerotic Cardiovascular Disease with Dementia After Stroke: A Retrospective Cohort Study
Journal of Alzheimer's Disease, 2020, 77, 1157-1167
2.76Citations (PDF)
82Neighbourhood environment and dementia in older people from high-, middle- and low-income countries: results from two population-based cohort studies
BMC Public Health, 2020, 20,
3.338Citations (PDF)
83Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study6.8127Citations (PDF)
84Towards the development of Vietnam’s national dementia plan—A commentary1.51Citations (PDF)
85Education, Special Needs, and Autism in the Baltic States: Policy Mapping in Estonia, Latvia, and Lithuania1.910Citations (PDF)
86Pooling individual participant data from randomized controlled trials: Exploring potential loss of information
PLoS ONE, 2020, 15, e0232970
2.53Citations (PDF)
87APOE ε4 and the Influence of Sex, Age, Vascular Risk Factors, and Ethnicity on Cognitive Decline3.638Citations (PDF)
88Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16
PLoS ONE, 2020, 15, e0229787
2.513Citations (PDF)
89Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis
Age and Ageing, 2020, 49, 939-947
1.8102Citations (PDF)
90Twenty-seven-year time trends in dementia incidence in Europe and the United States
Neurology, 2020, 95,
1.2392Citations (PDF)
91Cross-sectional and prospective relationship between occupational and leisure-time inactivity and cognitive function in an ageing population: the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study5.22Citations (PDF)
92Evidence Still Lacking for Recommendation of Screening for Cognitive Impairment in Older Adults
JAMA Internal Medicine, 2020, 180, 483
6.14Citations (PDF)
93Age-related reduction in motor adaptation: brain structural correlates and the role of explicit memory
Neurobiology of Aging, 2020, 90, 13-23
3.363Citations (PDF)
94NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain4.57Citations (PDF)
95TDP-43 Related Neuropathologies and Phosphorylation State: Associations with Age and Clinical Dementia in the Cambridge City over-75s Cohort2.713Citations (PDF)
96The Dementias Platform UK (DPUK) Data Portal5.467Citations (PDF)
97Social networks and cognitive function in older adults receiving home- and community-based aged care3.732Citations (PDF)
98Dependency ratios in healthy ageing
BMJ Global Health, 2020, 5, e002117
4.26Citations (PDF)
99We need to think about data governance for dementia research in a digital era6.816Citations (PDF)
100Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014
PLoS ONE, 2020, 15, e0241056
2.523Citations (PDF)
101Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use
Journal of Alzheimer's Disease, 2020, 74, 999-1009
2.77Citations (PDF)
102Mapping global evidence on strategies and interventions in neurotrauma and road traffic collisions prevention: a scoping review5.16Citations (PDF)
103Biopsychosocial Determinants of Cognitive Health in Later Life: The Harmonised Cognitive Assessment Protocol
Innovation in Aging, 2020, 4, 642-642
0.10Citations (PDF)
104Trends in Health Expectancies by Late-Life Disadvantage: The Cognitive Function and Ageing Studies
Innovation in Aging, 2020, 4, 640-640
0.10Citations (PDF)
105Multimorbidity, Disadvantage, and Trends in Disability-Free Life Expectancy: The CFAS Studies
Innovation in Aging, 2020, 4, 641-641
0.10Citations (PDF)
106Reply: LATE to the PART-y
Brain, 2019, 142, e48-e48
8.915Citations (PDF)
107Demographic, socioeconomic, and health correlates of unmet need for mental health treatment in the United States, 2002–16: evidence from the national surveys on drug use and health3.541Citations (PDF)
108Preventing dementia by preventing stroke: The Berlin Manifesto
Alzheimer's and Dementia, 2019, 15, 961-984
0.7288Citations (PDF)
109Prevention of Cognitive Decline: A Goal in Sight?2.78Citations (PDF)
110The experience of transitions in care in very old age: implications for general practice
Family Practice, 2019, 36, 778-784
2.516Citations (PDF)
111Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease
PLoS ONE, 2019, 14, e0218111
2.528Citations (PDF)
112Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study
PLoS Medicine, 2019, 16, e1002853
8.2118Citations (PDF)
113&lt;p&gt;Statin use and high-dose statin use after ischemic stroke in the UK: a retrospective cohort study&lt;/p&gt;
Clinical Epidemiology, 2019, Volume 11, 495-508
2.717Citations (PDF)
114Changes in Cognitive Impairment in the Czech Republic2.712Citations (PDF)
115Can General Practitioners manage mental disorders in primary care? A partially randomised, pragmatic, cluster trial
PLoS ONE, 2019, 14, e0224724
2.527Citations (PDF)
116Common bacterial infections and risk of incident cognitive decline or dementia: a systematic review protocol
BMJ Open, 2019, 9, e030874
2.08Citations (PDF)
117When Frail Older People Relocate in Very Old Age, Who Makes the Decision?0.118Citations (PDF)
118Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
BMC Geriatrics, 2019, 19,
3.349Citations (PDF)
119Two-decade change in prevalence of cognitive impairment in the UK5.455Citations (PDF)
120Living alone and cognitive function in later life3.7112Citations (PDF)
121Mediterranean diet adherence and cognitive function in older UK adults: the European Prospective Investigation into Cancer and Nutrition–Norfolk (EPIC-Norfolk) Study5.498Citations (PDF)
122Risk of Incident Dementia According to Metabolic Health and Obesity Status in Late Life: A Population-Based Cohort Study4.548Citations (PDF)
123Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Brain, 2019, 142, 1503-1527
8.91,275Citations (PDF)
124Autism prevalence in China is comparable to Western prevalence
Molecular Autism, 2019, 10,
4.7223Citations (PDF)
125Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 459-480
12.93,999Citations (PDF)
126History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
American Journal of Epidemiology, 2019, 188, 1228-1236
3.634Citations (PDF)
127General and abdominal adiposity and the risk of Parkinson's disease: A prospective cohort study1.812Citations (PDF)
128Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics, 2019, 51, 414-430
26.12,738Citations (PDF)
129John William Powles0.10Citations (PDF)
130Association between area deprivation and major depressive disorder in British men and women: a cohort study
BMJ Open, 2019, 9, e027530
2.045Citations (PDF)
131Is loneliness associated with increased health and social care utilisation in the oldest old? Findings from a population-based longitudinal study
BMJ Open, 2019, 9, e024645
2.035Citations (PDF)
132Mapping global evidence on strategies and interventions in neurotrauma and road traffic collisions prevention: a scoping review protocol
BMJ Open, 2019, 9, e031517
2.012Citations (PDF)
133Case finding for dementia during acute hospital admissions: a mixed-methods study exploring the impacts on patient care after discharge and costs for the English National Health Service
BMJ Open, 2019, 9, e026927
2.012Citations (PDF)
134Healthy ageing through internet counselling in the elderly (HATICE): a multinational, randomised controlled trial
The Lancet Digital Health, 2019, 1, e424-e434
14.8133Citations (PDF)
135Autism and the right to education in the EU: policy mapping and scoping review of Nordic countries Denmark, Finland, and Sweden
Molecular Autism, 2019, 10,
4.718Citations (PDF)
136The scale and profile of global dementia research funding
Lancet, The, 2019, 394, 1888-1889
14.825Citations (PDF)
137Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
PLoS ONE, 2019, 14, e0226349
2.516Citations (PDF)
138Autism and family involvement in the right to education in the EU: policy mapping in the Netherlands, Belgium and Germany
Molecular Autism, 2019, 10,
4.717Citations (PDF)
139Dementia research 2018: current and future population relevance
Lancet Neurology, The, 2019, 18, 3-5
12.91Citations (PDF)
140Older Adults' Reasons for Participating in an eHealth Prevention Trial: A Cross-Country, Mixed-Methods Comparison2.539Citations (PDF)
141Against the stream: early diagnosis of dementia, is it so desirable?
BJPsych Bulletin, 2019, 43, 123-125
1.124Citations (PDF)
142Strong and specific associations between cardiovascular risk factors and white matter micro- and macrostructure in healthy aging
Neurobiology of Aging, 2019, 74, 46-55
3.360Citations (PDF)
143Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2019, 18, 88-106
12.91,992Citations (PDF)
144Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis
Journal of Alzheimer's Disease, 2019, 70, S119-S144
2.7420Citations (PDF)
145Social isolation, cognitive reserve, and cognition in older people with depression and anxiety
Aging and Mental Health, 2019, 23, 1691-1700
2.795Citations (PDF)
146A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 20252.4100Citations (PDF)
147Traumatic brain injury and dementia
Lancet Psychiatry,the, 2018, 5, 383-384
5.03Citations (PDF)
148Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial2.745Citations (PDF)
149Identifying dementia cases with routinely collected health data: A systematic review
Alzheimer's and Dementia, 2018, 14, 1038-1051
0.7232Citations (PDF)
150Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II
Age and Ageing, 2018, 47, 220-225
1.893Citations (PDF)
151Prevalence of dementia in mainland China, Hong Kong and Taiwan: an updated systematic review and meta-analysis5.2145Citations (PDF)
152Dementia case-finding in hospitals: a qualitative study exploring the views of healthcare professionals in English primary care and secondary care
BMJ Open, 2018, 8, e020521
2.014Citations (PDF)
153Idalopirdine: another disappointment for people with dementia0.11Citations (PDF)
154A strong sense of coherence associated with reduced risk of anxiety disorder among women in disadvantaged circumstances: British population study
BMJ Open, 2018, 8, e018501
2.010Citations (PDF)
155The delirium and population health informatics cohort study protocol: ascertaining the determinants and outcomes from delirium in a whole population
BMC Geriatrics, 2018, 18,
3.316Citations (PDF)
156Lack of associations between modifiable risk factors and dementia in the very old: findings from the Cambridge City over-75s cohort study
Aging and Mental Health, 2018, 22, 1272-1278
2.756Citations (PDF)
157Cognitive reserve as a moderator of the negative association between mood and cognition: evidence from a population-representative cohort
Psychological Medicine, 2018, 48, 61-71
4.650Citations (PDF)
158TREM2 expression in the human brain: a marker of monocyte recruitment?
Brain Pathology, 2018, 28, 595-602
4.863Citations (PDF)
159Hippocampal sclerosis, hippocampal neuron loss patterns and TDP‐43 in the aged population
Brain Pathology, 2018, 28, 548-559
4.848Citations (PDF)
160Interventions to prevent and reduce excessive alcohol consumption in older people: a systematic review and meta-analysis
Age and Ageing, 2018, 47, 175-184
1.848Citations (PDF)
161Generalised anxiety disorder and hospital admissions: findings from a large, population cohort study
BMJ Open, 2018, 8, e018539
2.035Citations (PDF)
162Exploring causality of the association between smoking and Parkinson’s disease5.282Citations (PDF)
163Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet, The, 2018, 392, 1736-1788
14.86,480Citations (PDF)
164Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Lancet, The, 2018, 392, 1859-1922
14.82,697Citations (PDF)
165Opportunities and challenges in public and community engagement: the connected for cognitive health in later life (CHILL) project2.98Citations (PDF)
166Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals2.751Citations (PDF)
167Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet Neurology, The, 2018, 17, 939-953
12.92,269Citations (PDF)
168Aβ and the dementia syndrome: Simple versus complex perspectives3.214Citations (PDF)
169Evolution of dementia diagnosis over time (1988–2013): Evidence from French and English cohorts. Implication for secular trends analyses2.68Citations (PDF)
170Autism and the right to education in the EU: Policy mapping and scoping review of the United Kingdom, France, Poland and Spain
PLoS ONE, 2018, 13, e0202336
2.536Citations (PDF)
171Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet, The, 2018, 392, 1647-1661
14.8223Citations (PDF)
172Understanding the relationship between cognition and death: a within cohort examination of cognitive measures and mortality5.448Citations (PDF)
173Psychosocial aspects of successful ageing and resilience: critique, integration and implications / Aspectos psicológicos del envejecimiento exitoso y la resiliencia: crítica, integración e implicaciones
Estudios De Psicologia, 2018, 39, 248-266
0.416Citations (PDF)
174Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict3.518Citations (PDF)
175Accuracy of death certification of dementia in population-based samples of older people: analysis over time
Age and Ageing, 2018, 47, 589-594
1.841Citations (PDF)
176Dementia Research: Populations, Progress, Problems, and Predictions
Journal of Alzheimer's Disease, 2018, 64, S119-S143
2.76Citations (PDF)
177Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States
PLoS ONE, 2018, 13, e0199741
2.519Citations (PDF)
178Exploring patterns of response across the lifespan: the Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study
BMC Public Health, 2018, 18,
3.313Citations (PDF)
179Is frailty a stable predictor of mortality across time? Evidence from the Cognitive Function and Ageing Studies
Age and Ageing, 2018, 47, 721-727
1.854Citations (PDF)
18018F-FDG PET for Prediction of Conversion to Alzheimer’s Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy
Journal of Alzheimer's Disease, 2018, 64, 1175-1194
2.751Citations (PDF)
181The impact of dementia on service use by individuals with a comorbid health condition: a comparison of two cross-sectional analyses conducted approximately 10 years apart
BMC Medicine, 2018, 16,
7.545Citations (PDF)
182Association of Apathy With Risk of Incident Dementia
JAMA Psychiatry, 2018, 75, 1012
11.3115Citations (PDF)
183Social isolation, cognitive reserve, and cognition in healthy older people
PLoS ONE, 2018, 13, e0201008
2.5196Citations (PDF)
184Metallothionein‐I/II expression associates with the astrocyte DNA damage response and not Alzheimer‐type pathology in the aging brain
Glia, 2018, 66, 2316-2323
5.232Citations (PDF)
185Development of an Item Pool for a Needs-Based Measure of Quality of Life of Carers of a Family Member with Dementia
Patient, 2018, 12, 125-136
2.514Citations (PDF)
186Alcohol and older people: A systematic review of barriers, facilitators and context of drinking in older people and implications for intervention design
PLoS ONE, 2018, 13, e0191189
2.587Citations (PDF)
187Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment: the importance of apathy2.456Citations (PDF)
188Healthcare organisation and delivery for people with dementia and comorbidity: a qualitative study exploring the views of patients, carers and professionals
BMJ Open, 2017, 7, e013067
2.061Citations (PDF)
189Association of Delirium With Cognitive Decline in Late Life
JAMA Psychiatry, 2017, 74, 244
11.3236Citations (PDF)
190The Built Environment and Cognitive Disorders: Results From the Cognitive Function and Ageing Study II3.787Citations (PDF)
191Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?1.163Citations (PDF)
192Sex and gender in psychiatry5.06Citations (PDF)
193The changing picture of amyotrophic lateral sclerosis: lessons from European registers2.0112Citations (PDF)
194The changing prevalence and incidence of dementia over time — current evidence
Nature Reviews Neurology, 2017, 13, 327-339
27.5674Citations (PDF)
195Micro-scale environment and mental health in later life: Results from the Cognitive Function and Ageing Study II (CFAS II)
Journal of Affective Disorders, 2017, 218, 359-364
4.817Citations (PDF)
196Sex differences in the association between area deprivation and generalised anxiety disorder: British population study
BMJ Open, 2017, 7, e013590
2.021Citations (PDF)
197Neuropsychological profiles of vascular disease and risk of dementia: implications for defining vascular cognitive impairment no dementia (VCI-ND)
Age and Ageing, 2017, 46, 755-760
1.813Citations (PDF)
198Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
Lancet Neurology, The, 2017, 16, 620-629
12.9165Citations (PDF)
199Mitigation of disasters through community cohesion13.25Citations (PDF)
200Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease
Neurology, 2017, 88, 2321-2329
1.259Citations (PDF)
201Interpretation of dementia diagnosis and treatment trends in the UK over time
Lancet Public Health, The, 2017, 2, e128-e129
12.53Citations (PDF)
202Potential Value of Impaired Cognition in Stroke Prediction: A U.K. Population‐Based Study2.78Citations (PDF)
203Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 Individuals2.737Citations (PDF)
204Trends in Prevalence of Dementia in French Farmers from Two Epidemiological Cohorts2.731Citations (PDF)
205Dementia risk in renal dysfunction
Neurology, 2017, 88, 198-208
1.2122Citations (PDF)
206Dementia prevention — a call for contextualized evidence
Nature Reviews Neurology, 2017, 13, 579-580
27.511Citations (PDF)
207Trends in the incidence of dementia: design and methods in the Alzheimer Cohorts Consortium5.424Citations (PDF)
208Education and Successful Aging Trajectories: A Longitudinal Population-Based Latent Variable Modelling Analysis
Canadian Journal on Aging, 2017, 36, 427-434
1.522Citations (PDF)
209Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Lancet, The, 2017, 390, 1260-1344
14.81,813Citations (PDF)
210Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Nature Genetics, 2017, 49, 1373-1384
26.1948Citations (PDF)
211Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)
Lancet, The, 2017, 390, 1676-1684
14.8150Citations (PDF)
212Author response: Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies
Neurology, 2017, 89, 2214-2215
1.20Citations (PDF)
213Protocol for the Delirium and Cognitive Impact in Dementia (DECIDE) study: A nested prospective longitudinal cohort study
BMC Geriatrics, 2017, 17,
3.316Citations (PDF)
214Obesity in Older People With and Without Conditions Associated With Weight Loss: Follow-up of 955,000 Primary Care Patients3.646Citations (PDF)
215Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?
Brain Pathology, 2017, 27, 266-275
4.827Citations (PDF)
216[P3–573]: HEALTHY AGEING THROUGH INTERNET COUNSELLING IN THE ELDERLY (HATICE): AN ONGOING RANDOMISED CONTROLLED TRIAL0.71Citations (PDF)
217Sense of coherence as a coping mechanism for women with anxiety living in deprivation: a cohort study in the British population
Lancet, The, 2017, 390, S76
14.80Citations (PDF)
218Maximizing the Potential of Longitudinal Cohorts for Research in Neurodegenerative Diseases: A Community Perspective3.06Citations (PDF)
219Is Dementia Screening of Apparently Healthy Individuals Justified?1.724Citations (PDF)
220Improving data sharing in research with context-free encoded missing data
PLoS ONE, 2017, 12, e0182362
2.53Citations (PDF)
221Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations
PLoS ONE, 2017, 12, e0179521
2.568Citations (PDF)
222Dementia incidence trend over 1992-2014 in the Netherlands: Analysis of primary care data
PLoS Medicine, 2017, 14, e1002235
8.259Citations (PDF)
223Dying comfortably in very old age with or without dementia in different care settings – a representative “older old” population study
BMC Geriatrics, 2017, 17,
3.331Citations (PDF)
224Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study
PLoS Medicine, 2017, 14, e1002259
8.2276Citations (PDF)
225Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study
PLoS Medicine, 2017, 14, e1002261
8.2163Citations (PDF)
226Dementia and aging populations—A global priority for contextualized research and health policy
PLoS Medicine, 2017, 14, e1002275
8.277Citations (PDF)
227Retinal Nerve Fiber Layer Measures and Cognitive Function in the EPIC-Norfolk Cohort Study
2016, 57, 1921
33Citations (PDF)
228Barriers and Facilitators to the Uptake and Maintenance of Healthy Behaviours by People at Mid-Life: A Rapid Systematic Review
PLoS ONE, 2016, 11, e0145074
2.5274Citations (PDF)
229Relationship of Self-Rated Health to Stroke Incidence and Mortality in Older Individuals with and without a History of Stroke: A Longitudinal Study of the MRC Cognitive Function and Ageing (CFAS) Population
PLoS ONE, 2016, 11, e0150178
2.514Citations (PDF)
230Death and the Oldest Old: Attitudes and Preferences for End-of-Life Care - Qualitative Research within a Population-Based Cohort Study
PLoS ONE, 2016, 11, e0150686
2.599Citations (PDF)
231Using ambulance service PCRs to understand 999 call-outs to older people with dementia0.211Citations (PDF)
232Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment
BMJ Open, 2016, 6, e010806
2.081Citations (PDF)
233Lifestyle factors, cognitive reserve, and cognitive function: results from the Cognitive Function and Ageing Study Wales, a population-based cohort
Lancet, The, 2016, 388, S114
14.814Citations (PDF)
234Longitudinal course of behavioural and psychological symptoms of dementia: systematic review
British Journal of Psychiatry, 2016, 209, 366-377
2.3249Citations (PDF)
235A Novel Examination of Successful Aging Trajectories at the End of Life
Canadian Journal on Aging, 2016, 35, 533-540
1.56Citations (PDF)
236Alcohol in older people: systematic reviews of interventions and context
Lancet, The, 2016, 388, S64
14.83Citations (PDF)
237Land use mix and five-year mortality in later life: Results from the Cognitive Function and Ageing Study
Health and Place, 2016, 38, 54-60
4.018Citations (PDF)
238Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease4.988Citations (PDF)
239Preventing both stroke and dementia – Authors' reply
Lancet Neurology, The, 2016, 15, 659
12.90Citations (PDF)
240Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes
Neurology, 2016, 86, 1736-1743
1.2493Citations (PDF)
241Daytime napping and increased risk of incident respiratory diseases: symptom, marker, or risk factor?
Sleep Medicine, 2016, 23, 12-15
1.422Citations (PDF)
242METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research
Alzheimer's and Dementia, 2016, 12, 1235-1249
0.796Citations (PDF)
243Obesity associated with increased brain age from midlife
Neurobiology of Aging, 2016, 47, 63-70
3.3225Citations (PDF)
244Shared genetic contribution to ischemic stroke and Alzheimer's disease
Annals of Neurology, 2016, 79, 739-747
6.568Citations (PDF)
245Neuronal <scp>DNA</scp> damage response‐associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of <scp>A</scp>lzheimer‐type pathology3.337Citations (PDF)
246A systematic review of reviews on the prevalence of anxiety disorders in adult populations2.5653Citations (PDF)
247Longer-Lived Parents and Cardiovascular Outcomes1.218Citations (PDF)
248Reflections on cohort studies, life course and research into ageing5.23Citations (PDF)
249Microglial immunophenotype in dementia with Alzheimer’s pathology9.2191Citations (PDF)
250Trends in dementia incidence: Evolution over a 10‐year period in France
Alzheimer's and Dementia, 2016, 12, 272-280
0.793Citations (PDF)
251ICC-dementia (International Centenarian Consortium - dementia): an international consortium to determine the prevalence and incidence of dementia in centenarians across diverse ethnoracial and sociocultural groups
BMC Neurology, 2016, 16,
2.131Citations (PDF)
252Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study5.151Citations (PDF)
253A comparison of health expectancies over two decades in England: results of the Cognitive Function and Ageing Study I and II
Lancet, The, 2016, 387, 779-786
14.8157Citations (PDF)
254Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study5.461Citations (PDF)
255Defeating Alzheimer's disease and other dementias: a priority for European science and society
Lancet Neurology, The, 2016, 15, 455-532
12.91,469Citations (PDF)
256Dementia in western Europe: epidemiological evidence and implications for policy making
Lancet Neurology, The, 2016, 15, 116-124
12.9347Citations (PDF)
257Behavioural Risk Factors in Mid-Life Associated with Successful Ageing, Disability, Dementia and Frailty in Later Life: A Rapid Systematic Review
PLoS ONE, 2016, 11, e0144405
2.5142Citations (PDF)
258Who Lives Where and Does It Matter? Changes in the Health Profiles of Older People Living in Long Term Care and the Community over Two Decades in a High Income Country
PLoS ONE, 2016, 11, e0161705
2.549Citations (PDF)
259Cross Sectional Associations between Socio-Demographic Factors and Cognitive Performance in an Older British Population: The European Investigation of Cancer in Norfolk (EPIC-Norfolk) Study
PLoS ONE, 2016, 11, e0166779
2.510Citations (PDF)
260Physical Activity in Community Dwelling Older People: A Systematic Review of Reviews of Interventions and Context
PLoS ONE, 2016, 11, e0168614
2.5183Citations (PDF)
261Web-Based Interventions Targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis5.2133Citations (PDF)
262Validation of an a priori, index model of successful aging in a population-based cohort study: the successful aging index
International Psychogeriatrics, 2015, 27, 1971-1977
1.042Citations (PDF)
263Exploring the Underdiagnosis and Prevalence of Autism Spectrum Conditions in <scp>B</scp>eijing
Autism Research, 2015, 8, 250-260
5.147Citations (PDF)
264Prevalence of dementia in East Asia: a synthetic review of time trends2.456Citations (PDF)
265Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain
Brain Pathology, 2015, 25, 565-574
4.874Citations (PDF)
266Contextualizing the findings of a systematic review on patient and carer experiences of dementia diagnosis and treatment: a qualitative study
Health Expectations, 2015, 18, 740-753
3.123Citations (PDF)
267Harnessing the power of cohort studies for dementia research1.27Citations (PDF)
268CMHTs provide follow-up for patients with dementia and behavioural and psychological symptoms of dementia in both service models
BJPsych Bulletin, 2015, 39, 205-205
1.12Citations (PDF)
269Older people, the natural environment and common mental disorders: cross-sectional results from the Cognitive Function and Ageing Study
BMJ Open, 2015, 5, e007936
2.056Citations (PDF)
270Idiosyncratic responding during movie-watching predicted by age differences in attentional control
Neurobiology of Aging, 2015, 36, 3045-3055
3.391Citations (PDF)
271Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles6.810Citations (PDF)
272Community environment, cognitive impairment and dementia in later life: results from the Cognitive Function and Ageing Study
Age and Ageing, 2015, 44, 1005-1011
1.892Citations (PDF)
273Exploring attitudes and preferences for dementia screening in Britain: contributions from carers and the general public
BMC Geriatrics, 2015, 15,
3.319Citations (PDF)
274Social activity, cognitive decline and dementia risk: a 20-year prospective cohort study
BMC Public Health, 2015, 15,
3.3191Citations (PDF)
275A Reduced Astrocyte Response to β-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment
PLoS ONE, 2015, 10, e0118463
2.551Citations (PDF)
276Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review
PLoS ONE, 2015, 10, e0136181
2.5152Citations (PDF)
277The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration
PLoS ONE, 2015, 10, e0142388
2.5261Citations (PDF)
278Validation of existing diagnosis of autism in mainland China using standardised diagnostic instruments
Autism, 2015, 19, 1010-1017
6.024Citations (PDF)
279Worsening Cognitive Impairment and Neurodegenerative Pathology Progressively Increase Risk for Delirium1.0127Citations (PDF)
280A multimodal approach to dementia prevention: A report from the Cambridge Institute of Public Health4.942Citations (PDF)
281Genome‐wide association study of neocortical Lewy‐related pathology3.931Citations (PDF)
282Changing non-participation in epidemiological studies of older people: evidence from the Cognitive Function and Ageing Study I and II
Age and Ageing, 2015, 44, 867-873
1.842Citations (PDF)
283Relocation at older age: results from the Cognitive Function and Ageing Study
Journal of Public Health, 2015, 37, 480-487
2.230Citations (PDF)
284The nuclear retention of transcription factor FOXO3a correlates with a DNA damage response and increased glutamine synthetase expression by astrocytes suggesting a neuroprotective role in the ageing brain
Neuroscience Letters, 2015, 609, 11-17
2.063Citations (PDF)
285Does quality of life improve in octogenarians following cardiac surgery? A systematic review
BMJ Open, 2015, 5, e006904
2.039Citations (PDF)
286Interview with Dr Carol Brayne, 5 April 2013
Dementia, 2015, 14, 351-360
2.30Citations (PDF)
287Mild Cognitive Impairment Definitions: More Evolution Than Revolution3.09Citations (PDF)
288Sleep duration and risk of fatal and nonfatal stroke
Neurology, 2015, 84, 1072-1079
1.2225Citations (PDF)
289Cross-cultural Perspectives of Successful Aging: Young Turks and Europeans
Educational Gerontology, 2015, 41, 800-813
1.41Citations (PDF)
290The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: A systematic review2.0111Citations (PDF)
291Ageing, health, and social care: reframing the discussion
Lancet, The, 2015, 385, 1699-1700
14.89Citations (PDF)
292Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly6.813Citations (PDF)
293Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology5.441Citations (PDF)
294Dementia prevention: call to action
Lancet, The, 2015, 386, 1625
14.821Citations (PDF)
295Common polygenic variation enhances risk prediction for Alzheimer’s disease
Brain, 2015, 138, 3673-3684
8.9422Citations (PDF)
296A memory clinic <i>v</i>. traditional community mental health team service: comparison of costs and quality
BJPsych Bulletin, 2015, 39, 6-11
1.117Citations (PDF)
297Younger Europeans’ Conceptualizations of Successful Aging2.72Citations (PDF)
298Development of the Standards of Reporting of Neurological Disorders (STROND) checklist
Neurology, 2015, 85, 821-828
1.266Citations (PDF)
299Dementia priority setting partnership with the James Lind Alliance: using patient and public involvement and the evidence base to inform the research agenda
Age and Ageing, 2015, 44, 985-993
1.8105Citations (PDF)
300Successful ageing trajectories at the end of life: a longitudinal population-based cohort study
Lancet, The, 2015, 386, S31
14.81Citations (PDF)
301Area deprivation and generalised anxiety disorder in a British community cohort: findings from the EPIC-Norfolk study
Lancet, The, 2015, 386, S67
14.83Citations (PDF)
302Attitudes and preferences towards screening for dementia: a systematic review of the literature
BMC Geriatrics, 2015, 15,
3.387Citations (PDF)
303Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies2.4458Citations (PDF)
304Convergent genetic and expression data implicate immunity in Alzheimer's disease
Alzheimer's and Dementia, 2015, 11, 658-671
0.7187Citations (PDF)
305Nutrition and the Prevalence of Dementia in Mainland China, Hong Kong, and Taiwan: An Ecological Study
Journal of Alzheimer's Disease, 2015, 44, 1099-1106
2.75Citations (PDF)
306Age‐Associated White Matter Lesions: The <scp>MRC C</scp>ognitive <scp>F</scp>unction and <scp>A</scp>geing <scp>S</scp>tudy
Brain Pathology, 2015, 25, 35-43
4.892Citations (PDF)
307A neuronal <scp>DNA</scp> damage response is detected at the earliest stages of <scp>A</scp>lzheimer's neuropathology and correlates with cognitive impairment in the <scp>M</scp>edical <scp>R</scp>esearch <scp>C</scp>ouncil's <scp>C</scp>ognitive <scp>F</scp>unction and <scp>A</scp>geing <scp>S</scp>tudy ageing brain cohort3.345Citations (PDF)
308Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease
Biological Psychiatry, 2015, 77, 711-719
1.575Citations (PDF)
309Dementia prediction for people with stroke in populations: is mild cognitive impairment a useful concept?
Age and Ageing, 2015, 44, 78-83
1.819Citations (PDF)
310Successful Aging and Frailty: Mutually Exclusive Paradigms or Two Ends of a Shared Continuum?0.915Citations (PDF)
311Validation of a Consensus Method for Identifying Delirium from Hospital Records
PLoS ONE, 2014, 9, e111823
2.576Citations (PDF)
312Whose "successful ageing"?: lay- and researcher-driven conceptualisations of ageing well1.536Citations (PDF)
313Daytime napping, sleep duration and serum C reactive protein: a population-based cohort study
BMJ Open, 2014, 4, e006071
2.067Citations (PDF)
314Comorbidity and dementia: a scoping review of the literature
BMC Medicine, 2014, 12,
7.5371Citations (PDF)
315Parental concerns, socioeconomic status, and the risk of autism spectrum conditions in a population-based study2.441Citations (PDF)
316Cohort Profile: A prospective cohort study of objective physical and cognitive capability and visual health in an ageing population of men and women in Norfolk (EPIC-Norfolk 3)5.288Citations (PDF)
317Reporting standards for studies of diagnostic test accuracy in dementia
Neurology, 2014, 83, 364-373
1.2198Citations (PDF)
318Mild cognitive impairment—not always what it seems
Nature Reviews Neurology, 2014, 10, 130-131
27.519Citations (PDF)
319Education associated with a delayed onset of terminal decline
Age and Ageing, 2014, 43, 26-31
1.833Citations (PDF)
320Place of death and end-of-life transitions experienced by very old people with differing cognitive status: Retrospective analysis of a prospective population-based cohort aged 85 and over
Palliative Medicine, 2014, 28, 220-233
3.460Citations (PDF)
321C-reactive protein, APOE genotype and longitudinal cognitive change in an older population
Age and Ageing, 2014, 43, 289-292
1.847Citations (PDF)
322Grouping of behavioural and psychological symptoms of dementia2.4141Citations (PDF)
323(Unsuccessful) Binary Modeling of Successful Aging in the Oldest‐Old Adults: A Call for Continuum‐Based Measures2.723Citations (PDF)
324The Continuing Challenge of Turning Promising Observational Evidence About Risk for Dementia to Evidence Supporting Prevention
JAMA Internal Medicine, 2014, 174, 333
6.12Citations (PDF)
325Depression and other behavioral and psychological symptoms of dementia – separate research worlds in need of a common understanding1.07Citations (PDF)
326Cognitive function in a general population of men and women: a cross sectional study in the European Investigation of Cancer–Norfolk cohort (EPIC-Norfolk)
BMC Geriatrics, 2014, 14,
3.333Citations (PDF)
327Assessing environmental features related to mental health: a reliability study of visual streetscape images
BMC Public Health, 2014, 14,
3.334Citations (PDF)
328The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing
BMC Neurology, 2014, 14,
2.1624Citations (PDF)
329The incidence of Parkinson's disease in the North-East of England
Age and Ageing, 2014, 43, 257-263
1.828Citations (PDF)
330Self-reported sleep patterns in a British population cohort
Sleep Medicine, 2014, 15, 295-302
1.449Citations (PDF)
331Cognitive lifestyle jointly predicts longitudinal cognitive decline and mortality risk5.495Citations (PDF)
332Health-related quality of life in the Cambridge City over-75s Cohort (CC75C): development of a dementia-specific scale and descriptive analyses
BMC Geriatrics, 2014, 14,
3.35Citations (PDF)
333Psychometric Properties of the Mandarin Version of the Childhood Autism Spectrum Test (CAST): An Exploratory Study2.319Citations (PDF)
334Comparison between a Mandarin Chinese version of the Childhood Autism Spectrum Test and the Clancy Autism Behaviour Scale in mainland China2.447Citations (PDF)
335Daytime Napping and the Risk of All-Cause and Cause-Specific Mortality: A 13-Year Follow-up of a British Population
American Journal of Epidemiology, 2014, 179, 1115-1124
3.6124Citations (PDF)
336Integrating the molecular and the population approaches to dementia research to help guide the future development of appropriate therapeutics
Biochemical Pharmacology, 2014, 88, 652-660
5.27Citations (PDF)
337Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease
Neurobiology of Aging, 2014, 35, 2883.e3-2883.e10
3.39Citations (PDF)
338Attitudes and preferences towards screening for dementia: a systematic review
Lancet, The, 2014, 384, S49
14.81Citations (PDF)
339Instruments to measure behavioural and psychological symptoms of dementia2.439Citations (PDF)
340Focus on positive features of ageing
Nature, 2014, 514, 35-35
34.33Citations (PDF)
341Operational definitions of successful aging: a systematic review1.0426Citations (PDF)
342<scp>DNA</scp> damage response and senescence in endothelial cells of human cerebral cortex and relation to <scp>A</scp>lzheimer's neuropathology progression: a population‐based study in the <scp>M</scp>edical <scp>R</scp>esearch <scp>C</scp>ouncil <scp>C</scp>ognitive <scp>F</scp>unction and <scp>A</scp>geing <scp>S</scp>tudy (<scp>MRC</scp>‐<scp>CFAS</scp>) cohort3.339Citations (PDF)
343Dementia: Time trends and policy responses
Maturitas, 2014, 79, 191-195
1.715Citations (PDF)
344Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
Lancet Neurology, The, 2014, 13, 788-794
12.92,200Citations (PDF)
345The descriptive epidemiology of delirium symptoms in a large population-based cohort study: results from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
BMC Geriatrics, 2014, 14,
3.341Citations (PDF)
346The Mandarin Childhood Autism Spectrum Test (CAST): Sex Differences2.312Citations (PDF)
347Hospital costs associated with depression in a cohort of older men living in Western Australia2.514Citations (PDF)
348Improving access to psychological therapies and older people: Findings from the Eastern Region4.133Citations (PDF)
349Period, birth cohort and prevalence of dementia in mainland China, Hong Kong and Taiwan: a meta‐analysis2.434Citations (PDF)
350A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease
Lancet Neurology, The, 2014, 13, 532-534
12.927Citations (PDF)
351The Blackfriars Consensus on brain health and dementia
Lancet, The, 2014, 383, 1805-1806
14.862Citations (PDF)
352TDP-43 Pathology in the Population: Prevalence and Associations with Dementia and Age2.743Citations (PDF)
353Risk Factors and Screening Methods for Detecting Dementia: A Narrative Review
Journal of Alzheimer's Disease, 2014, 42, S329-S338
2.724Citations (PDF)
354Adapting to Dementia in Society: A Challenge for Our Lifetimes and a Charge for Public Health
Journal of Alzheimer's Disease, 2014, 42, 1151-1163
2.77Citations (PDF)
355Pain reporting in older adults: the influence of cognitive impairment – results from the Cambridge City &gt;75 Cohort study
British Journal of Pain, 2014, 8, 119-124
1.67Citations (PDF)
356O2-11-03: COHORT STUDIES HAVE A ROLE TO PLAY IN DEMENTIA RESEARCH
2014, 10, P189-P189
1Citations (PDF)
357The association between community environment and cognitive function: a systematic review2.9159Citations (PDF)
358Integrating Data for Modeling Biological Complexity
2014, , 921-949
2Citations (PDF)
359Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
PLoS ONE, 2014, 9, e94661
2.5163Citations (PDF)
360From Molecule to Clinic and Community for Neurodegeneration: Research to Bridge Translational Gaps
Journal of Alzheimer's Disease, 2013, 33, S385-S396
2.75Citations (PDF)
361Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis
Molecular Autism, 2013, 4, 7
4.7168Citations (PDF)
362Determinants of delayed diagnosis in Parkinson’s disease
Journal of Neurology, 2013, 260, 1978-1981
3.583Citations (PDF)
363The Epidemiology of Delirium: Challenges and Opportunities for Population Studies1.0102Citations (PDF)
364Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Nature Genetics, 2013, 45, 1452-1458
26.14,276Citations (PDF)
365UK health performance: findings of the Global Burden of Disease Study 2010
Lancet, The, 2013, 381, 997-1020
14.8505Citations (PDF)
366What determines the self-rated health of older individuals with stroke compared to other older individuals? A cross-sectional analysis of the Medical Research Council Cognitive Function and Aging Study
BMC Geriatrics, 2013, 13,
3.322Citations (PDF)
367COSMIC (Cohort Studies of Memory in an International Consortium): An international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups
BMC Neurology, 2013, 13,
2.167Citations (PDF)
368Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Lancet Neurology, The, 2013, 12, 822-838
12.94,859Citations (PDF)
369The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD
Molecular Neurobiology, 2013, 48, 556-570
3.742Citations (PDF)
370A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
Lancet, The, 2013, 382, 1405-1412
14.8888Citations (PDF)
371What is available for case identification in autism research in mainland China?2.127Citations (PDF)
372A review of healthcare service and education provision of Autism Spectrum Condition in mainland China2.447Citations (PDF)
373The Mandarin Chinese version of the childhood autism spectrum test (CAST): Test–retest reliability2.48Citations (PDF)
374Cognitive Decline and Dementia Risk in Older Adults With Psychotic Symptoms: A Prospective Cohort Study1.051Citations (PDF)
375A commentary on studies presenting projections of the future prevalence of dementia
BMC Public Health, 2013, 13,
3.31,252Citations (PDF)
376A Global Model for Effective Use and Evaluation of e-Learning in Health2.6137Citations (PDF)
377Service provision for autism in mainland China: A service providers’ perspective2.435Citations (PDF)
378Service provision for autism in mainland China: Preliminary mapping of service pathways4.549Citations (PDF)
379The presence of behavioural and psychological symptoms and progression to dementia in the cognitively impaired older population2.412Citations (PDF)
380Transient neurological symptoms in the older population: report of a prospective cohort study—the Medical Research Council Cognitive Function and Ageing Study (CFAS)
BMJ Open, 2013, 3, e003195
2.011Citations (PDF)
381Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
BMJ Open, 2013, 3, e001909
2.0118Citations (PDF)
382Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis
Neurology, 2013, 80, 829-838
1.2156Citations (PDF)
383Association between depression and hospital outcomes among older men
Cmaj, 2013, 185, 117-123
1.448Citations (PDF)
384Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis
BMJ, The, 2013, 347, f5125-f5125
0.2167Citations (PDF)
385Deathless models of aging and the importance of acknowledging the dying process
Cmaj, 2013, 185, 751-752
1.414Citations (PDF)
386On the Success of the Successful Aging Paradigm2.016Citations (PDF)
387Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores
Age and Ageing, 2013, 42, 649-653
1.812Citations (PDF)
388The association between social stress and global cognitive function in a population-based study: the European Prospective Investigation into Cancer (EPIC)-Norfolk study
Psychological Medicine, 2013, 43, 655-666
4.616Citations (PDF)
389Cytomegalovirus infection is associated with increased mortality in the older population
Aging Cell, 2013, 12, 381-387
7.0196Citations (PDF)
390Instruments to measure behavioural and psychological symptoms of dementia: changing use over time2.46Citations (PDF)
391Lay perspectives of successful ageing: a systematic review and meta-ethnography
BMJ Open, 2013, 3, e002710
2.0178Citations (PDF)
392The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort2.0630Citations (PDF)
393Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study
BMJ Open, 2013, 3, e002414
2.033Citations (PDF)
394The pros and cons of early diagnosis in dementia1.356Citations (PDF)
395Health-related quality-of-life instruments for Alzheimer's disease and mixed dementia1.058Citations (PDF)
396Self-Rated Health and Cardiovascular Disease Incidence: Results from a Longitudinal Population-Based Cohort in Norfolk, UK
PLoS ONE, 2013, 8, e65290
2.579Citations (PDF)
397Cognitive and social lifestyle: links with neuropathology and cognition in late life
Acta Neuropathologica, 2013, 127, 137-150
7.8122Citations (PDF)
398Prevalence Studies of Dementia in Mainland China, Hong Kong and Taiwan: A Systematic Review and Meta-Analysis
PLoS ONE, 2013, 8, e66252
2.5109Citations (PDF)
399Variation Over Time in the Association between Polypharmacy and Mortality in the Older Population
Drugs and Aging, 2012, 28, 547-560
3.583Citations (PDF)
400Psychosocial Factors That Shape Patient and Carer Experiences of Dementia Diagnosis and Treatment: A Systematic Review of Qualitative Studies
PLoS Medicine, 2012, 9, e1001331
8.2211Citations (PDF)
401The Neuropathology of Vascular Disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
Current Alzheimer Research, 2012, 9, 687-696
1.562Citations (PDF)
402Neuropathological Correlates of Falling in the CC75C Population-Based Sample of the Older Old
Current Alzheimer Research, 2012, 9, 697-708
1.54Citations (PDF)
403Neuropathological Profile of Mild Cognitive Impairment From a Population Perspective1.516Citations (PDF)
404The Role of Variation at AβPP, PSEN1, PSEN2, and MAPT in Late Onset Alzheimer's Disease2.757Citations (PDF)
405Active Cognitive Lifestyle Associates with Cognitive Recovery and a Reduced Risk of Cognitive Decline2.786Citations (PDF)
406Alzheimer and Vascular Neuropathological Changes Associated with Different Cognitive States in a Non-Demented Sample2.737Citations (PDF)
407Gender Differences in Verbal Learning in Older Participants
Aging Health, 2012, 8, 493-507
0.414Citations (PDF)
408Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet, The, 2012, 380, 2197-2223
14.87,567Citations (PDF)
409Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet, The, 2012, 380, 2163-2196
14.87,081Citations (PDF)
410Making Alzheimer's and dementia research fit for populations
Lancet, The, 2012, 380, 1441-1443
14.889Citations (PDF)
411Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation
Neurobiology of Aging, 2012, 33, 1843.e9-1843.e17
3.326Citations (PDF)
412What sleep characteristics predict cognitive decline in the elderly?
Sleep Medicine, 2012, 13, 886-892
1.4252Citations (PDF)
413Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems6.831Citations (PDF)
414Impact of Less Common and “Disregarded” Neurodegenerative Pathologies on Dementia Burden in a Population-Based Cohort2.734Citations (PDF)
415Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia
Neurobiology of Aging, 2012, 33, 791-803
3.351Citations (PDF)
416Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study
Brain, 2012, 135, 2809-2816
8.9522Citations (PDF)
417Examining the influence of gender, education, social class and birth cohort on MMSE tracking over time: a population-based prospective cohort study
BMC Geriatrics, 2012, 12,
3.358Citations (PDF)
418The Epidemiological Neuropathology of Dementia and the Implications for Drug Development3.07Citations (PDF)
419Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia
Biological Psychiatry, 2012, 71, 783-791
1.589Citations (PDF)
420Systematic reviews on behavioural and psychological symptoms in the older or demented population6.848Citations (PDF)
421The Association between Depressive Symptoms and Non-Psychiatric Hospitalisation in Older Adults
PLoS ONE, 2012, 7, e34821
2.545Citations (PDF)
422Public health and ageing
2012, , 244-256
0Citations (PDF)
423Active Cognitive Lifestyle Is Associated with Positive Cognitive Health Transitions and Compression of Morbidity from Age Sixty-Five
PLoS ONE, 2012, 7, e50940
2.597Citations (PDF)
424Epidemiology of Alzheimer disease
Nature Reviews Neurology, 2011, 7, 137-152
27.51,433Citations (PDF)
425The natural history of treated Parkinson's disease in an incident, community based cohort2.0223Citations (PDF)
426Measurement of stressful postures during daily activities: An observational study with older people
Gait and Posture, 2011, 34, 397-401
1.210Citations (PDF)
427Full-scale scores of the Mini Mental State Examination can be generated from an abbreviated version4.117Citations (PDF)
428Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort
Neuroscience Letters, 2011, 505, 25-30
2.094Citations (PDF)
429Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype
Neurobiology of Aging, 2011, 32, 1795-1807
3.3177Citations (PDF)
430A European perspective on population studies of dementia0.736Citations (PDF)
431Alzheimer's disease
Lancet, The, 2011, 377, 1019-1031
14.82,292Citations (PDF)
432Epidemiological Neuropathology: The MRC Cognitive Function and Aging Study Experience2.7112Citations (PDF)
433The association between late-life cognitive test scores and retrospective informant interview data1.09Citations (PDF)
434Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study2.7569Citations (PDF)
435Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Nature Genetics, 2011, 43, 429-435
26.11,892Citations (PDF)
436No major effect of twinning on autistic traits
Autism Research, 2011, 4, 377-382
5.125Citations (PDF)
437Brain Iron Dysregulation and the Risk of Ageing White Matter Lesions
NeuroMolecular Medicine, 2011, 13, 289-299
3.819Citations (PDF)
438The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study2.954Citations (PDF)
439No evidence that extended tracts of homozygosity are associated with Alzheimer's disease1.817Citations (PDF)
440Risk for dementia and age at measurement2.411Citations (PDF)
441Are terminal decline and its potential indicators detectable in population studies of the oldest old?2.416Citations (PDF)
442Health expectancies in the older Thai population3.78Citations (PDF)
443Epidemiology of back pain in older adults: prevalence and risk factors for back pain onset
Rheumatology, 2011, 50, 1645-1653
2.0146Citations (PDF)
444Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research
Age and Ageing, 2011, 40, 501-507
1.844Citations (PDF)
445Mortality in carotid sinus hypersensitivity: a cohort study
BMJ Open, 2011, 1, e000020
2.09Citations (PDF)
446Neuropathological correlates of late-life depression in older people
British Journal of Psychiatry, 2011, 198, 109-114
2.3168Citations (PDF)
447Limitations in physical functioning among older people as a predictor of subsequent disability in instrumental activities of daily living
Age and Ageing, 2011, 40, 463-469
1.878Citations (PDF)
448Cognitive Lifestyle and Long-Term Risk of Dementia and Survival After Diagnosis in a Multicenter Population-based Cohort
American Journal of Epidemiology, 2011, 173, 1004-1012
3.6112Citations (PDF)
449Prevalence of anxiety and its correlates among older adults in Latin America, India and China: cross-cultural study
British Journal of Psychiatry, 2011, 199, 485-491
2.3109Citations (PDF)
450The neuropathological profile of mild cognitive impairment (MCI): a systematic review
Molecular Psychiatry, 2011, 17, 1056-1076
8.4119Citations (PDF)
451Are Autism Spectrum Conditions More Prevalent in an Information-Technology Region? A School-Based Study of Three Regions in the Netherlands2.377Citations (PDF)
452Education, occupation and retirement age effects on the age of onset of Alzheimer's disease2.440Citations (PDF)
453Primary care and dementia: 2. long‐term care at home: psychosocial interventions, information provision, carer support and case management2.472Citations (PDF)
454Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance2.43Citations (PDF)
455Time for a Change in the Research Paradigm for Alzheimer's Disease: The Value of a Chaotic Matrix Modeling Approach5.112Citations (PDF)
456One size fits all? Why we need more sophisticated analytical methods in the explanation of trajectories of cognition in older age and their potential risk factors1.053Citations (PDF)
457Place of death for the ‘oldest old’: ≥85-year-olds in the CC75C population-based cohort1.332Citations (PDF)
458Behavioural and psychological symptoms in the older population without dementia - relationship with socio-demographics, health and cognition
BMC Geriatrics, 2010, 10,
3.347Citations (PDF)
459The Oldest Old in the Last Year of Life: Population‐Based Findings from Cambridge City over‐75s Cohort Study Participants Aged 85 and Older at Death2.748Citations (PDF)
460Systematic review of statins for the prevention of vascular dementia or dementia1.831Citations (PDF)
461Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
PLoS ONE, 2010, 5, e13950
2.5381Citations (PDF)
462APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study
Age and Ageing, 2010, 39, 104-111
1.811Citations (PDF)
463Design for independent living: activity demands and capabilities of older people
Ageing and Society, 2010, 30, 1239-1255
2.711Citations (PDF)
464The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
Brain, 2010, 133, 1328-1341
8.9244Citations (PDF)
465Education, the brain and dementia: neuroprotection or compensation?
Brain, 2010, 133, 2210-2216
8.9332Citations (PDF)
466Dementia risk prediction in the population: are screening models accurate?
Nature Reviews Neurology, 2010, 6, 318-326
27.5142Citations (PDF)
467Optimizing Mild Cognitive Impairment for Discriminating Dementia Risk in the General Older Population1.038Citations (PDF)
468Alterations of the blood–brain barrier in cerebral white matter lesions in the ageing brain
Neuroscience Letters, 2010, 486, 246-251
2.071Citations (PDF)
469Are optimal levels of testosterone associated with better cognitive function in healthy older women and men?2.056Citations (PDF)
470Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain
Neurobiology of Aging, 2010, 31, 578-590
3.3354Citations (PDF)
471Polymorphisms in LMNA and near a SERPINA gene cluster are associated with cognitive function in older people
Neurobiology of Aging, 2010, 31, 1563-1568
3.312Citations (PDF)
472S2-02-01: How do MCI syndromes map?
2010, 6, S91-S91
0Citations (PDF)
473What do we mean by Alzheimer's disease?
BMJ: British Medical Journal, 2010, 341, c4670-c4670
0.158Citations (PDF)
474Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe
Scientific World Journal, The, 2009, 9, 1463-1475
2.933Citations (PDF)
475Trachoma survey methods: a literature review2.453Citations (PDF)
476Prevalence of autism-spectrum conditions: UK school-based population study
British Journal of Psychiatry, 2009, 194, 500-509
2.3781Citations (PDF)
477Assessing the risk of dementia in the aging population
Nature Reviews Neurology, 2009, 5, 417-418
27.58Citations (PDF)
478Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways
Stroke, 2009, 40, 369-375
5.184Citations (PDF)
479Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study
Brain, 2009, 132, 1324-1334
8.9207Citations (PDF)
480Patterns of Functional Loss Among Older People: A Prospective Analysis
Human Factors, 2009, 51, 669-680
4.546Citations (PDF)
481Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study
PLoS Medicine, 2009, 6, e1000180
8.2246Citations (PDF)
482Recovery in instrumental activities of daily living (IADLs): findings from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
Age and Ageing, 2009, 38, 663-668
1.819Citations (PDF)
483Education Differences in Life Expectancy With Cognitive Impairment3.634Citations (PDF)
484Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review
BMC Neurology, 2009, 9,
2.1170Citations (PDF)
485Primary care and dementia: 1. diagnosis, screening and disclosure2.4175Citations (PDF)
486Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Nature Genetics, 2009, 41, 1088-1093
26.12,895Citations (PDF)
487Risk factors for trachomatous trichiasis in children: cross-sectional household surveys in Southern Sudan1.413Citations (PDF)
488Age, Neuropathology, and Dementia
New England Journal of Medicine, 2009, 360, 2302-2309
25.1832Citations (PDF)
489Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population
British Journal of Psychiatry, 2009, 194, 212-219
2.3342Citations (PDF)
490Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)6.890Citations (PDF)
491The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Brain, 2009, 132, 2958-2969
8.9929Citations (PDF)
492What Does the Pediatrician Need to Know About Alzheimer Disease?1.83Citations (PDF)
493Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study2.7172Citations (PDF)
494Systematic Review of the Prevalence and Incidence of Parkinson’s Disease in Asia
Journal of Epidemiology, 2009, 19, 281-293
2.6151Citations (PDF)
495More testing needed
BMJ: British Medical Journal, 2009, 339, b2825-b2825
0.11Citations (PDF)
496What Will Happen If We Do Nothing To Control Trachoma: Health Expectancies for Blinding Trachoma in Southern Sudan3.24Citations (PDF)
497The Q-CHAT (Quantitative CHecklist for Autism in Toddlers): A Normally Distributed Quantitative Measure of Autistic Traits at 18–24 Months of Age: Preliminary Report2.3261Citations (PDF)
498The Childhood Autism Spectrum Test (CAST): Sex Differences2.376Citations (PDF)
499Falls in advanced old age: recalled falls and prospective follow-up of over-90-year-olds in the Cambridge City over-75s Cohort study
BMC Geriatrics, 2008, 8,
3.372Citations (PDF)
500Co‐occurrence of anxiety and depressive disorders in a community sample of older people: results from the MRC CFAS (Medical Research Council Cognitive Function and Ageing Study)2.469Citations (PDF)
501Mild cognitive impairment in the older population: Who is missed and does it matter?2.445Citations (PDF)
502Two‐Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree?2.7207Citations (PDF)
503A comparison of parametric models for the investigation of the shape of cognitive change in the older population
BMC Neurology, 2008, 8,
2.121Citations (PDF)
504An investigation of the population impact of variation in HbA1clevels in older people in England and Wales: From a population based multi-centre longitudinal study3.358Citations (PDF)
505Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study
Psychoneuroendocrinology, 2008, 33, 1013-1022
2.5129Citations (PDF)
506The oldest old in England and Wales: a descriptive analysis based on the MRC Cognitive Function and Ageing Study
Age and Ageing, 2008, 37, 396-402
1.848Citations (PDF)
507Education and trajectories of cognitive decline over 9 years in very old people: methods and risk analysis
Age and Ageing, 2008, 38, 277-282
1.857Citations (PDF)
508Primary Care Screening for Dementia and Mild Cognitive Impairment—Reply7.31Citations (PDF)
509Community-level socio-economic status and cognitive and functional impairment in the older population0.394Citations (PDF)
510Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up
BMJ: British Medical Journal, 2008, 336, 258-262
0.1363Citations (PDF)
511The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS)
Age and Ageing, 2008, 38, 319-325
1.853Citations (PDF)
512Vascular factors and prevention of dementia2.840Citations (PDF)
513Does depression predict adverse outcomes for older medical inpatients? A prospective cohort study of individuals screened for a trial
Age and Ageing, 2008, 37, 690-695
1.840Citations (PDF)
514Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease
Human Molecular Genetics, 2008, 17, 759-767
3.139Citations (PDF)
515Inability to get up after falling, subsequent time on floor, and summoning help: prospective cohort study in people over 90
BMJ: British Medical Journal, 2008, 337, a2227-a2227
0.1247Citations (PDF)
516Associations between Active Trachoma and Community Intervention with Antibiotics, Facial Cleanliness, and Environmental Improvement (A,F,E)3.243Citations (PDF)
517Effectiveness of liaison psychiatric nursing in older medical inpatients with depression: a randomised controlled trial
Age and Ageing, 2007, 36, 436-442
1.825Citations (PDF)
518Blindness Survey Methods: Response from Sudan Study Authors
PLoS Medicine, 2007, 4, e86
8.20Citations (PDF)
519Educational differences in the dynamics of disability incidence, recovery and mortality: Findings from the MRC Cognitive Function and Ageing Study (MRC CFAS)5.281Citations (PDF)
520Operationalisation of Mild Cognitive Impairment: A Graphical Approach
PLoS Medicine, 2007, 4, e304
8.257Citations (PDF)
521Prevalence and symptomatology of depression in older people living in institutions in England and Wales
Age and Ageing, 2007, 36, 562-568
1.8119Citations (PDF)
522Cohort Profile: The Cambridge City over-75s Cohort (CC75C)5.252Citations (PDF)
523Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants
Human Molecular Genetics, 2007, 16, 865-873
3.1270Citations (PDF)
524The Childhood Asperger Syndrome Test (CAST)
Autism, 2007, 11, 173-185
6.042Citations (PDF)
525Estimated life expectancy of Parkinson's patients compared with the UK population2.0139Citations (PDF)
526Dementia Screening in Primary Care7.3128Citations (PDF)
527Prevalence of depression in older people in England and Wales: the MRC CFA Study
Psychological Medicine, 2007, 37, 1787-1795
4.6156Citations (PDF)
528The Burden of Diseases on Disability-Free Life Expectancy in Later Life3.6144Citations (PDF)
529Reaching the population with dementia drugs: what are the challenges?2.431Citations (PDF)
530The epidemiology of low vision and blindness associated with trichiasis in southern Sudan1.611Citations (PDF)
531The elephant in the room — healthy brains in later life, epidemiology and public health
Nature Reviews Neuroscience, 2007, 8, 233-239
20.4202Citations (PDF)
532Using the Mini‐Mental State Examination for Tracking Cognition in the Older Population Based on Longitudinal Data2.728Citations (PDF)
533Early Cognitive Change in the General Population: How Do Different Definitions Work?2.7115Citations (PDF)
534Cohort differences in disease and disability in the young-old: findings from the MRC Cognitive Function and Ageing Study (MRC-CFAS)3.351Citations (PDF)
535Systematic review of the depressive symptoms associated with vascular conditions4.821Citations (PDF)
536Prevalence of Risk Factors and Severity of Active Trachoma in Southern Sudan: An Ordinal Analysis3.931Citations (PDF)
537Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study
Lancet, The, 2006, 368, 589-595
14.861Citations (PDF)
538Incidence of Dementia in England and Wales1.58Citations (PDF)
539Four Components Describe Behavioral Symptoms in 1,120 Individuals with Late‐Onset Alzheimer's Disease2.7134Citations (PDF)
540Self-rated health status as a predictor of death, functional and cognitive impairment: a longitudinal cohort study
European Journal of Ageing, 2006, 3, 193-206
3.2121Citations (PDF)
541Risk of dementia in diabetes mellitus: a systematic review
Lancet Neurology, The, 2006, 5, 64-74
12.91,992Citations (PDF)
542Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review
BMC Neurology, 2006, 6,
2.199Citations (PDF)
543The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort
BMC Neurology, 2006, 6,
2.119Citations (PDF)
544An investigation of whether factors associated with short-term attrition change or persist over ten years: data from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)3.365Citations (PDF)
545Regional differences in multidimensional aspects of health: findings from the MRC cognitive function and ageing study3.324Citations (PDF)
546A longitudinal study regarding conversion from mild memory impairment to dementia in a Japanese community2.438Citations (PDF)
547Screening for depression in older medical inpatients2.458Citations (PDF)
548What is the evidence for a premorbid parkinsonian personality: A systematic review
Movement Disorders, 2006, 21, 1066-1072
5.3144Citations (PDF)
549White Matter Lesions in an Unselected Cohort of the Elderly
Stroke, 2006, 37, 1391-1398
5.1555Citations (PDF)
550DAPK1 variants are associated with Alzheimer's disease and allele-specific expression
Human Molecular Genetics, 2006, 15, 2560-2568
3.1127Citations (PDF)
551Carotid Sinus Hypersensitivity in Asymptomatic Older Persons4.4174Citations (PDF)
552Dementia before Death in Ageing Societies— The Promise of Prevention and the Reality
PLoS Medicine, 2006, 3, e397
8.2127Citations (PDF)
553Risk factors for incident dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study. A population-based nested case–control study
Age and Ageing, 2006, 35, 154-160
1.8127Citations (PDF)
554Blinding Trachoma in Postconflict Southern Sudan
PLoS Medicine, 2006, 3, e478
8.243Citations (PDF)
555Prevalence and Causes of Blindness and Low Vision in Southern Sudan
PLoS Medicine, 2006, 3, e477
8.253Citations (PDF)
556Screening for autism spectrum disorders
Autism, 2006, 10, 11-35
6.043Citations (PDF)
557Cohort Profile: The Medical Research Council Cognitive Function and Ageing Study (CFAS)†5.2107Citations (PDF)
558The Childhood Asperger Syndrome Test (CAST)
Autism, 2006, 10, 415-427
6.057Citations (PDF)
559Self-reported parkinsonian symptoms in the EPIC-Norfolk cohort
BMC Neurology, 2005, 5,
2.113Citations (PDF)
560Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study1.837Citations (PDF)
561A systematic review of prevalence studies of dementia in Parkinson's disease
Movement Disorders, 2005, 20, 1255-1263
5.31,135Citations (PDF)
562A genome wide linkage disequilibrium screen in Parkinson’s disease
Journal of Neurology, 2005, 252, 597-602
3.57Citations (PDF)
563The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study
PLoS Medicine, 2005, 2, e193
8.2114Citations (PDF)
564The CAST (Childhood Asperger Syndrome Test)
Autism, 2005, 9, 45-68
6.0177Citations (PDF)
565Diseases and Impairments as Risk Factors for Onset of Disability in the Older Population in England and Wales: Findings From the Medical Research Council Cognitive Function and Ageing Study3.6105Citations (PDF)
566A systematic review of prevalence and incidence studies of dementia with Lewy bodies
Age and Ageing, 2005, 34, 561-566
1.8316Citations (PDF)
567A systematic review of nutritional risk factors of Parkinson's disease
Nutrition Research Reviews, 2005, 18, 259-282
5.744Citations (PDF)
568Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community
Age and Ageing, 2005, 34, 242-248
1.8158Citations (PDF)
569Global prevalence of dementia: a Delphi consensus study
Lancet, The, 2005, 366, 2112-2117
14.84,715Citations (PDF)
570Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease
Neuroscience Letters, 2005, 374, 124-128
2.038Citations (PDF)
571A systematic literature review of attrition between waves in longitudinal studies in the elderly shows a consistent pattern of dropout between differing studies4.1392Citations (PDF)
572Challenges in the epidemiological investigation of the relationships between physical activity, obesity, diabetes, dementia and depression
Neurobiology of Aging, 2005, 26, 6-10
3.327Citations (PDF)
573Attrition and bias in the MRC cognitive function and ageing study: an epidemiological investigation3.3142Citations (PDF)
574Neutrophil counts, monocyte counts and cardiovascular disease in the elderly
Experimental Gerontology, 2004, 39, 615-619
3.826Citations (PDF)
575Analysis of longitudinal studies with death and drop‐out: a case study
Statistics in Medicine, 2004, 23, 2215-2226
1.8135Citations (PDF)
576Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease
Neuroscience Letters, 2004, 358, 142-146
2.045Citations (PDF)
577Adverse experience in childhood as a developmental risk factor for altered immune status in adulthood1.441Citations (PDF)
578Survival in a population sample is predicted by proportions of lymphocyte subsets4.681Citations (PDF)
579Inflammatory dispositions: a population-based study of the association between hostility and peripheral leukocyte counts2.613Citations (PDF)
580Association of depression with peripheral leukocyte counts in EPIC-Norfolk—role of sex and cigarette smoking2.028Citations (PDF)
581Brief Report Prevalence of Autism Spectrum Conditions in Children Aged 5-11 Years in Cambridgeshire, UK
Autism, 2002, 6, 231-237
6.0157Citations (PDF)
582The CAST (Childhood Asperger Syndrome Test)
Autism, 2002, 6, 9-31
6.0359Citations (PDF)
583Immune measures which predict 9-year survival in an elderly population sample0.04Citations (PDF)
584Cross-cultural comparison of the Mini-Mental State Examination in United Kingdom and United States participants with Alzheimer's disease2.415Citations (PDF)
585The distribution of Mini-Mental State Examination scores in an older UK African-Caribbean population compared to MRC CFA study norms2.435Citations (PDF)
586The heterogeneity of idiopathic Parkinson's disease
Journal of Neurology, 2002, 249, 138-145
3.5227Citations (PDF)
587The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease
NeuroReport, 2001, 12, 631-634
1.557Citations (PDF)
588Health and ill-health in the older population in England and Wales
Age and Ageing, 2001, 30, 53-62
1.870Citations (PDF)
589Commentary: Searching for risks for Alzheimer's disease5.21Citations (PDF)
590Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery2.449Citations (PDF)
591Alzheimer disease is not associated with polymorphisms in the angiotensinogen and renin genes2.216Citations (PDF)
592Longitudinal studies of ageing: a key role in the evidence base for improving health and quality of life in older adults
Age and Ageing, 2000, 29, 485-486
1.88Citations (PDF)
593Cognitive function in UK community-dwelling African Caribbean and white elders: a pilot study2.437Citations (PDF)
594Decline across different domains of cognitive function in normal ageing: results of a longitudinal population-based study using CAMCOG2.4109Citations (PDF)
595Very old drivers: findings from a population cohort of people aged 84 and over5.287Citations (PDF)
596Staging of Cytoskeletal and β-Amyloid Changes in Human Isocortex Reveals Biphasic Synaptic Protein Response during Progression of Alzheimer’s Disease
American Journal of Pathology, 2000, 157, 623-636
3.5179Citations (PDF)
597Influence of Apolipoprotein E Genotype on the Risk of Cognitive Deterioration in Moderate Drinkers and Smokers
Epidemiology, 2000, 11, 280-284
3.1116Citations (PDF)
598Factors Associated with Functional Decline and Improvement in a Very Elderly Community-dwelling Population3.6110Citations (PDF)
599α-2 macroglobulin polymorphism and Alzheimer disease risk in the UK
Nature Genetics, 1999, 22, 16-17
26.194Citations (PDF)
600Title is missing!5.448Citations (PDF)
601Public Health, Epidemiology and Geriatric Psychiatry1.00Citations (PDF)
602Estimating the True Extent of Cognitive Decline in the Old Old2.773Citations (PDF)
603Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals
Experimental Gerontology, 1998, 33, 593-600
3.891Citations (PDF)
604Key Papers in Geriatric Psychiatry: mini-mental state: a practical method for grading the cognitive state of patients for the clinician. M. Folstein, S. Folstein and P. McHugh,Journal of Psychiatric Research, 1975,12, 189-198.2.4116Citations (PDF)
605Changes in self-rated health, disability and contact with services in a very elderly cohort: a 6-year follow-up study
Age and Ageing, 1998, 27, 23-33
1.879Citations (PDF)
606Cognitive impairment: a challenge for community care. A comparison of the domiciliary service receipt of cognitively impaired and equally dependent physically impaired elderly women
Age and Ageing, 1997, 26, 301-308
1.820Citations (PDF)
607Attitudes Toward Death: A Community Study of Octoagenarians and Nonagenarians1.017Citations (PDF)
608Setting the minimal metrically detectable change on disability rating scales1.398Citations (PDF)
609SUICIDAL THINKING IN COMMUNITY RESIDENTS OVER EIGHTY
1997, 12, 337-343
46Citations (PDF)
610Local population differences and the needs of people with cognitive impairment
1997, 12, 883-887
4Citations (PDF)
611Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70-79 at baseline
1997, 12, 1107-1118
30Citations (PDF)
612SURVEYING AFRICAN CARIBBEAN ELDERS IN THE COMMUNITY: IMPLICATIONS FOR RESEARCH ON HEALTH AND HEALTH SERVICE USE2.413Citations (PDF)
613Cross-cultural research into cognitive impairment and dementia: some practical experiences2.419Citations (PDF)
614WHAT BECOMES OF PEOPLE WITH DEMENTIA REFERRED TO COMMUNITY PSYCHOGERIATRIC TEAMS?2.46Citations (PDF)
615CARERS AND THE MONITORING OF PSYCHOGERIATRIC COMMUNITY TEAMS
1996, 11, 1057-1061
7Citations (PDF)
616Psychometric properties of the CAMCOG and its efficacy in the diagnosis of dementia1.774Citations (PDF)
617Depressive symptoms in the very elderly?their prevalence and significance2.440Citations (PDF)
618CAMCOG—A concise neuropsychological test to assist dementia diagnosis: Socio‐demographic determinants in an elderly population sample5.6229Citations (PDF)
619Examination of phosphorylated tau protein as a PHF-precursor at early stage alzheimer's disease
Neurobiology of Aging, 1995, 16, 433-445
3.336Citations (PDF)
620The prevalence of depression in a cohort of the very elderly4.843Citations (PDF)
621Quantitative analysis of tau protein in paired helical filament preparations: Implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease
Neurobiology of Aging, 1995, 16, 409-417
3.363Citations (PDF)
622Something in the heir: Royal succession and the elderly2.40Citations (PDF)
623Clinicopathological Studies of the Dementias from an Epidemiological Viewpoint
British Journal of Psychiatry, 1993, 162, 439-446
2.328Citations (PDF)
624Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings
Annals of Neurology, 1991, 30, 381-390
6.5332Citations (PDF)
625The prevalence of vascular dementia in europe: Facts and fragments from 1980–1990 studies
Annals of Neurology, 1991, 30, 817-824
6.5146Citations (PDF)
626Estimation of verbal intelligence in an elderly community: A prediction analysis using a shortened NART5.643Citations (PDF)
627The case identification of dementia in the community: A comparison of methods2.450Citations (PDF)
628The Association of Education and Socioeconomic Status with the Mini Mental State Examination and the Clinical Diagnosis of Dementia in Elderly People
Age and Ageing, 1990, 19, 91-96
1.8193Citations (PDF)
629Estimation of verbal intelligence in an elderly community: An epidemiological study using NART5.630Citations (PDF)
630An Epidemiological Study of Dementia in a Rural Population of Elderly Women
British Journal of Psychiatry, 1989, 155, 214-219
2.3108Citations (PDF)
631NORMAL AGEING, IMPAIRED COGNITIVE FUNCTION, AND SENILE DEMENTIA OF THE ALZHEIMER'S TYPE: A CONTINUUM?
Lancet, The, 1988, 331, 1265-1267
14.8185Citations (PDF)
632IS ALZHEIMER'S DISEASE DISTINCT FROM NORMAL AGEING?
Lancet, The, 1988, 332, 514-515
14.88Citations (PDF)
633Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies2.577Citations (PDF)
634Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias2.5141Citations (PDF)
635Solanezumab and the amyloid hypothesis for Alzheimer’s disease
BMJ, The, 0, , i6771
0.235Citations (PDF)
636Anticholinergic drugs and risk of dementia: case-control study0.1395Citations (PDF)
637The determinants of cognitive decline and dementia0.12Citations (PDF)
638Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto4.818Citations (PDF)
639France removes state funding for dementia drugs
BMJ, The, 0, , l6930
0.218Citations (PDF)
640Aducanumab for Alzheimer’s disease?
BMJ, The, 0, , n1682
0.2152Citations (PDF)